Position in CELC
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$104,620
New position
Shares Held
1,000
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#224
of 273 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $164,908 across 8 Biotechnology names. CELC ranks #1 (63.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
This page
|
1,000 | $104,620 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
612 | $33,623 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,000 | $16,970 | |
| 4 | CRMD |
CorMedix Inc.
|
610 | $4,788 | |
| 5 | EXEL |
Exelixis, Inc.
|
80 | $4,352 | |
| 6 | ATNM |
Actinium Pharmaceuticals, Inc.
|
341 | $334 | |
| 7 | ELDN |
Eledon Pharmaceuticals, Inc.
|
35 | $137 | |
| 8 | INO |
Inovio Pharmaceuticals, Inc.
|
77 | $84 |
All Filings in CELC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,620 | 1,000 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||